Home

Allan Camaisa, CEO and Chairman: Calidi Biotherapeutics CLDI Sell · Filed 24/12/18

Trade details

Type
Insider sale
Amount
$16,200
Shares · price
10,000 sh · $1.62 a share
Held after
66,712 sh
Trade date
24/12/17
Filed
24/12/18
Days to filing
1 days

Sold 13.0% of holdings

Share of holding sold
13.0%

Calidi Biotherapeutics trades, last 26 weeks

What else happened in Calidi Biotherapeutics around then

Filed or reported within 30 days of the trade day · 24/11/17~25/01/16

Allan Camaisa's recent trades

  • Allan Camaisa

    SellCalidi Biotherapeutics

    $1,241

    Filed 25/12/16